Ashlee Wheeler - 18 Apr 2025 Form 3 Insider Report for Torrid Holdings Inc. (CURV)

Role: Title - Chief Strategy and Planning Officer; Exhibit 24 - Power of Attorney
Signature: /s/ Bridgett C. Zeterberg, as Attorney-in-Fact for Ashlee Wheeler
Issuer symbol: CURV
Transactions as of: 18 Apr 2025
Net transactions value: $0
Form type: 3
Filing time: 16 May 2025, 16:20:08 UTC
Next filing: 03 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Wheeler Ashlee	Title - Chief Strategy and Planning Officer; Exhibit 24 - Power of Attorney	C/O TORRID HOLDINGS INC., 18501 EAST SAN JOSE AVENUE, CITY OF INDUSTRY	/s/ Bridgett C. Zeterberg, as Attorney-in-Fact for Ashlee Wheeler	16 May 2025	0002067624

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CURV	Common Stock						126,377	18 Apr 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CURV	Option to purchase shares							18 Apr 2025	Common Stock	9,524	$21.00	Direct	F2
holding	CURV	Option to purchase shares							18 Apr 2025	Common Stock	14,577	$6.06	Direct	F3
holding	CURV	Option to purchase shares							18 Apr 2025	Common Stock	36,983	$5.75	Direct	F4
holding	CURV	Option to purchase shares							18 Apr 2025	Common Stock	64,433	$3.23	Direct	F5
holding	CURV	Option to purchase shares							18 Apr 2025	Common Stock	44,965	$4.51	Direct	F6
holding	CURV	Option to purchase shares							18 Apr 2025	Common Stock	11,038	$7.42	Direct	F7
holding	CURV	Option to purchase shares							18 Apr 2025	Common Stock	56,819	$5.60	Direct	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents (1) 34,125 shares of common stock outstanding, (2) 1,192 restricted stock units (RSUs) that remain unvested from a grant of 4,762 RSUs which started vesting on July 6, 2022; (3) 2,063 RSUs that remain unvested from a grant of 8,251 RSUs which started vesting on March 31, 2023t; (4) 10,870 RSUs that remain unvested from a grant of 21,740 RSUs which started vesting on September 2, 2023; (5) 19,350 RSUs that remain unvested from a grant of 38,700 RSUs which started vesting on March 27, 2024; (6) 20,788 RSUs that remain unvested from a grant of 27,717 RSUs which started vesting on April 2, 2025; (7) 6,739 RSUs that remain unvested from a grant of 6,739 RSUs which will start to vest on July 1, 2025; (8) 31,250 RSUs that remain unvested from a grant of 31,250 RSUs which will start to vest on March 25, 2026. All grants of RSUs vest in substantially equal 25% installments. Vesting is subject to the reporting person's continued employment through the applicable vesting date.
F2	Represents options to purchase shares that started vesting on June 30, 2022 and become exercisable in substantially equal 25% installments on each of June 30, 2022, June 30, 2023, June 30, 2024 and June 30, 2025, subject to the reporting person's continued employment through the applicable vesting date.
F3	Represents options to purchase shares that started vesting on March 31, 2023 and become exercisable in substantially equal 25% installments on each of March 31, 2023, March 31, 2024, March 31, 2025 and March 31, 2026, subject to the reporting person's continued employment through the applicable vesting date.
F4	Represents options to purchase shares that started vesting on September 2, 2023 and become exercisable in substantially equal 25% installments on each of September 2, 2023, September 2, 2024, September 2, 2025 and September 2, 2026, subject to the reporting person's continued employment through the applicable vesting date.
F5	Represents options to purchase shares that started vesting on March 27, 2024 and become exercisable in substantially equal 25% installments on each of March 27, 2024, March 27, 2025, March 27, 2026 and March 27, 2027, subject to the reporting person's continued employment through the applicable vesting date.
F6	Represents options to purchase shares that started vesting on April 2, 2025 and become exercisable in substantially equal 25% installments on each of April 2, 2025, April 2, 2026, April 2, 2027 and April 2, 2028, subject to the reporting person's continued employment through the applicable vesting date.
F7	Represents options to purchase shares that will start to vest on July 1, 2025 and become exercisable in substantially equal 25% installments on each of July 1, 2025, July 1, 2026, July 1, 2027 and July 1, 2028, subject to the reporting person's continued employment through the applicable vesting date.
F8	Represents options to purchase shares that will start to vest on March 25, 2026 and become exercisable in substantially equal 25% installments on each of March 25, 2026, March 25, 2027, March 25, 2028 and March 25, 2029, subject to the reporting person's continued employment through the applicable vesting date.

Remarks:

Title - Chief Strategy and Planning Officer; Exhibit 24 - Power of Attorney